SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 26, 2006
PDI, INC. |
(Exact name of registrant as specified in its charter) |
Delaware | | 0-24249 | | 22-2919486 |
(State or other jurisdiction of incorporation) | | (Commission File Number) | | (I.R.S. Employer Identification No.) |
Saddle River Executive Centre 1 Route 17 South Saddle River, NJ 07458 |
(Address of principal executive office) |
Registrant’s telephone number, including area code: (201) 258-8450 |
Not Applicable |
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |
Item 8.01 Other Events.
On September 26, 2006, PDI, Inc. (the “Company”) issued a press release announcing that it has received verbal notification from GlaxoSmithKline of its intention not to renew its fee for service contract sales engagement with the Company for 2007.
A copy of the press release is attached as Exhibit 99.1 hereto and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(c) Exhibits
| 99.1 | Press Release dated September 26, 2006. |
* * * * * * *
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PDI, INC.
By: /s/ Michael Marquard
------------------------------------
Michael Marquard
Chief Executive Officer
Date: September 26, 2006
EXHIBIT INDEX
Exhibit No. Description
___________ ____________
99.1 Press Release dated September 26, 2006
EXHIBIT 99.1
